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We screened cord blood or serum samples from 101 infants at risk for congenital syphilis and serum samples
from their mothers for immunoglobulin G (IgG), IgM, and IgA antibodies to Treponema paUlidum by Western
blotting (immunoblotting). Clinical evaluation showed that six infants had signs and/or symptoms consistent
with congenital syphilis. The sera from five of these infants were IgM blot positive, and four were IgA blot
positive. Four asymptomatic infants had serologic evidence of congenital syphilis. The sera from three of these
infants were IgM blot positive, and two were IgA blot positive. However, the IgM reactivity of the serum from
one asymptomatic infant, which was also IgA positive, was abolished by protein G treatment. An IgM capture
enzyme-linked immunosorbent assay corroborated the presence of IgM antibodies in six of seven IgM
blot-reactive sera. Overall, for detection of symptomatic congenital syphilis, a sensitivity of 83% for IgM
blotting and 67% for IgA blotting was obtained. The significance of positive IgM or IgA Western blots for
asymptomatic infants requires further study to confirm infection in these infants.
As a consequence of the increased incidence of syphilis in
women of childbearing age (6), cases of congenital syphilis
have been on the rise in the United States (2). Although the
early increase in 1990 was at least partly due to changes in the
case definition of congenital syphilis (5), the continued in-
creases reflect a true increase in disease incidence. The
diagnosis of symptomatic congenital syphilis can be made on
clinical grounds when the infection and treatment history of
the mother is known. However, up to 60% of infants with
congenital syphilis are asymptomatic at birth (15). Addition-
ally, since the maternal treatment history is not always known,
a reliable laboratory test to diagnose infection is desirable. For
these reasons, there is great interest in improving methods of
laboratory diagnosis of this disease.
Because standard serologic tests for syphilis detect both
immunoglobulin (Ig) G and IgM, including transplacentally
acquired maternal IgG, they cannot be used to provide a
laboratory diagnosis of congenital syphilis when a single serum
sample is tested (11). An exception to this occurs, however,
when the titer for the infant is fourfold or more higher than
that for the mother. A variety of IgM-specific assays have been
developed to overcome this problem. The previously unreli-
able fluorescent treponemal antibody absorption (FTA-ABS)
test for IgM (12) has been modified (19S IgM FTA-ABS assay)
to improve its performance but is of limited availability (15).
IgM-specific enzyme-linked immunosorbent assays (ELISAs)
and Western blot (WB) (immunoblotting) tests for congenital
syphilis have also been developed (3, 4, 7, 8, 16, 17, 19, 20,
23-26, 28, 29, 32). In addition to serologic tests, the rabbit
infectivity test and PCR have been studied for their applica-
bility to diagnosis of this disease and show promise (9, 24).
We evaluated the IgM and IgA WB as a screening test for
the diagnosis of congenital syphilis in a group of 101 newborn
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infants at risk for congenital syphilis. The IgM WB demon-
strated good sensitivity for detection of symptomatically in-
fected infants. However, its use for asymptomatically infected
infants at risk for congenital syphilis requires further confir-
mation of infection by alternative means.
MATERIALS AND METHODS
Study population. Consecutive cord blood and serum sam-
ples from 101 infants at risk for congenital syphilis and serum
samples from their mothers were collected over a 1-year period
(February 1991 to February 1992) at the Carolinas Medical
Center, Charlotte, N.C., and at the University of North Caro-
lina Hospitals, Chapel Hill, N.C. An infant was defined as
being at risk for congenital syphilis if it was born to a mother
with a reactive serologic test for syphilis regardless of maternal
treatment history. All maternal and infant samples were col-
lected within 24 h of delivery except for one mother-infant
pair, which was collected 2.5 months after delivery. Sera were
stored frozen at - 20°C and not thawed until assayed by WB.
For this retrospective study, WBs were performed blindly,
without knowledge of the clinical findings for the infants.
Serologic tests for syphilis. All maternal and infant sera
were tested for nontreponemal and treponemal antibodies by
standard serologic tests. The Venereal Disease Research Lab-
oratory (VDRL) test was performed as recommended by the
manufacturer on all infant and maternal samples. Eighty-five
of the maternal sera were also tested by the FTA-ABS test
(Incstar Corporation, Stillwater, Minn.), performed according
to the manufacturer's instructions.
Treponema pallidum preparation. T. pallidum Nichols was
obtained by intratesticular inoculation of New Zealand White
rabbits. When peak orchitis was reached, testicles were re-
moved, rinsed in phosphate-buffered saline (PBS), and
minced. PBS with 10% heat-inactivated normal rabbit serum
was added to the minced testicles, and the treponemes were
extracted by repeated rounds of agitation (98 rpm) at 32°C
followed by centrifugation at 400 x g and aspiration of the
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supernatant. Supernatants were pooled and centrifuged at
10,000 x g for 15 min at 4°C. The treponemal cell pellet was
resuspended in PBS, and the treponemes were quantitated by
dark-field microscopy, aliquoted, and frozen at - 70°C.
WB. T pallidum organisms (1.25 x 10') were solubilized in
10 mM Tris-1 mM EDTA-1% sodium dodecyl sulfate (SDS)
by boiling for 3 min. Samples were then mixed with equal
volumes of 2x sample buffer (125 mM Tris, 4% SDS, 20%
glycerol, 2% 2-mercaptoethanol, 0.001% bromphenol blue).
Proteins were separated by SDS-polyacrylamide gel electro-
phoresis (PAGE) in gels (14 by 16 cm; 4% acrylamide stacking
gels and 15% acrylamide separating gels) with 25 mM Tris-192
mM glycine-0.1% SDS running buffer (13). Gels were run at
150 V for 4 h (SE 400 Electrophoresis Unit; Hoefer Scientific,
San Francisco, Calif.). An single lane of the gel contained
molecular mass markers (SDS-PAGE standards, low range;
Bio-Rad Laboratories Inc., Hercules, Calif.). Proteins were
transferred to nitrocellulose (0.45 p.m) by the method of
Towbin et al. (30) at 195 mA for 1 h and then at 50 mA for 2
h (Bio-Rad Trans-blot Cell; Bio-Rad Laboratories Inc.). Ni-
trocellulose sheets were blocked in PBS (7 mM Na2HPO4, 2.8
mM NaHIPO4, 145 mM NaCl [pH 7.2]) with 0.05% Tween 20
and 3% nonfat dry milk for 1 h at room temperature, rinsed in
distilled water, cut into strips, and stored at - 20°C until use.
Sera and controls were diluted 1:100 in PBS-Tween-milk and
incubated with strips overnight at room temperature with
agitation. After three washes in PBS-Tween-milk, appropri-
ately diluted, isotype-specific, horseradish peroxidase-conju-
gated secondary antibodies to human IgG, IgM, or IgA
(Organon Teknika Corporation, West Chester, Pa.) were
added and incubated for 1 h at room temperature with
agitation. The strips were washed three times, and the sub-
strate 4-chloro-1-naphthol (Sigma Chemical Co., St. Louis,
Mo.) was added and incubated at room temperature. Color
development was stopped by rinsing the strips in distilled
water. IgM and IgA blots were considered positive if any
reactivity was apparent.
IgM capture ELISA. Cord blood or serum samples from 8 of
10 infants with serologic and/or clinical evidence of congenital
syphilis were analyzed by an IgM capture enzyme-linked
immunosorbent assay (ELISA; DCL-Captia Syphilis-M; Diag-
nostic Chemicals, Limited, Oxford, Conn.). The assays were
performed according to the manufacturer's instructions.
IgM separation. The IgM fraction of cord blood or serum
was obtained by protein G affinity separation with Quik-Sep
IgM vials (Isolab, Inc., Akron, Ohio). These vials contain
recombinant protein G, which removes all subclasses of IgG
from serum. Briefly, 50 pl of serum was added to an absorption
vial containing recombinant protein G, vortexed for 10 s, and
placed on a rocking platform for 10 min at room temperature.
A porous disk was then placed into the vial and pushed to the
bottom, and the supernatant was removed and used for blots.
The supernatant, which is collected at a 1:8 dilution, was
diluted 1:12.5 (final dilution, 1:100), equivalent to the dilution
of whole serum used. All samples from infants with clinical
and/or serologic evidence of congenital syphilis were assayed
with absorbed cord blood or serum in addition to whole cord
blood and serum.
RF detection. Cord blood and serum samples from 8 of 10
infants with clinical and/or serologic evidence of congenital
syphilis (Table 1) were tested for the presence of rheumatoid
factor (RF) by latex agglutination (Rheuma-Lex; Trinity Lab-
oratories Inc., Raleigh, N.C.). Assays were performed accord-
ing to the manufacturer's instructions. Briefly, 40 ,ul of serum
was added to 1 drop of latex reagent, mixed, and rotated at 100
rpm for 2 min. Agglutination reactions were observed under a
TABLE 1. Clinical and serologic findings for infants with
suspected congenital syphilis'
Serum VDRL WB"
Infant titer IgM RF
no. ELISA
Mother Infant IgM IgA
Symptomatic
21 1:256 1:128 + + + +
32 1:64 1:512 + + + +
50 1:128 1:64 + + + +
56 1:64 1:16 - - + -
66 1:128 1:16 + - + -
117 1:512 1:256 + + ND' ND
Asymptomatic
68 1:32 1:16 + - + -
76 1:256 1:128 + - - ND
96 1:32 1:2 - + ND -
103 1:2 1:2 + + + +
" Includes all infants with clinical and/or serologic (reactive IgM and/or IgA
WB) evidence of congenital syphilis. Sera were not numbered consecutively for
this study.
+, reactivity to any protein; -, complete lack of reactivity.
ND, not determined.
"IgM reactivity removed by absorption with protein G.
bright light and scored as positive (any degree of agglutination)
or negative (complete lack of agglutination).
Chart reviews. The medical records of all 101 infants at risk
for congenital syphilis were examined retrospectively to deter-
mine whether any had signs or symptoms consistent with
congenital syphilis at birth (11). When documented, the treat-
ment history of the mother for syphilis was noted.
RESULTS
Serologic tests for syphilis in infants and their mothers.
One hundred and one infants and 85 of the VDRL-reactive
mothers were included in this study. Maternal VDRL titers
ranged from reactive undiluted to 1:512. Eighty-one of the
maternal sera were reactive by FTA-ABS (data not shown).
VDRL titers for the infants ranged from nonreactive to 1:512.
In only one case did an infant (no. 32) have a VDRL titer
(1:512) higher than that of its mother (1:64, Table 1). This
infant's sample was also reactive in IgM and IgA WB (dis-
cussed below).
Clinical findings for infants at risk for congenital syphilis.
Analysis of the infants' medical records revealed six infants
(no. 21, 32, 50, 56, 66, and 117) with one or more clinical
findings consistent with congenital syphilis (Table 1). The most
frequent finding was evidence of bone involvement by X-ray
(five infants), followed by prematurity (three infants), liver
involvement (three infants), seizures (one infant), pneumonia
(one infant), thrombocytopenia (one infant), hearing loss (one
infant), and rash (one infant). A seventh infant (no. 76)
without clinical signs had a reactive (1:1) cerebrospinal fluid
VDRL test.
IgG WBs. Eighty-five of 101 maternal and all 101 infant cord
blood and serum samples were analyzed by IgG WB. The WBs
for six symptomatic infants (Table 1) and their mothers were
compared (Fig. 1). In general, mother and infant IgG results
were similar. However, sera from three infants (data for one
not shown) with symptoms suggestive of congenital syphilis
demonstrated a band of greater intensity than the mother's
serum (Fig. 1, lanes 4 and 6). This band corresponded to a
protein with a molecular mass of approximately 83 kDa. The
pattern of IgG reactivity in asymptomatic infants with IgM-
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FIG. 1. IgG WB of maternal (odd-numbered lanes) and corre-
sponding infant (even-numbered lanes) sera. All five infants had
symptoms consistent with congenital syphilis. Lanes 1 and 2, mother
and infant 21; lanes 3 and 4, mother and infant 32; lanes 5 and 6,
mother and infant 50; lanes 7 and 8, mother and infant 56; lanes 9 and
10, mother and infant 66.
and/or IgA-reactive blots (Table 1) and their mothers was
similar.
IgM WBs. All infant cord blood and serum samples and 85
of 101 maternal serum samples were analyzed for the presence
of IgM antibodies to T. pallidum by WB with an IgM-specific
secondary antibody. The effect of RF and IgG on IgM WB
reactivity was assessed by absorption of IgG from the 10 infant
samples listed in Table 1 with protein G. Eight of 101 infant
sera demonstrated reactivity in IgM WBs (Table 1, Fig. 2). Five
of the eight were from symptomatic infants, and the other
three were from asymptomatic infants. Seven of the eight sera
reacted with the 47-kDa antigen. Variable reactivity was
observed to antigens of 45 kDa and lower. One serum (infant
no. 76) reacted solely to an antigen of approximately 93 kDa
(not shown).
Absorption of IgG from infant cord blood and serum





FIG. 2. Examples of reactive and nonreactive IgM WBs. Lane 1,
negative control; lane 2, negative control absorbed with protein G;
lane 3, positive control. Lanes 4, 6, 8, 10, 12, 14, 16, and 18, unabsorbed
serum from infants 21, 32, 50, 56, 66, 68, 96, and 103, respectively.
Lanes 5, 7, 9, 11, 13, 15, 17, and 19, protein G-absorbed serum from
infants 21, 32, 50, 56, 66, 68, 96, and 103, respectively.
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FIG. 3. Examples of reactive and nonreactive IgA WBs. Lane 1,
negative control; lane 2, negative control absorbed with protein G;
lane 3, positive control. Lanes 4, 6, 8, 10, 12, 14, 16, and 18, unabsorbed
serum from infants 21, 32, 50, 56, 66, 68, 96, and 103, respectively.
Lanes 5, 7, 9, 11, 13, 15, 17, and 19, protein G-absorbed serum from
infants 21, 32, 50, 56, 66, 68, 96, and 103, respectively. The blot for
infant 96 (lanes 16 and 17) gave a weak reaction to the 47-kDa antigen
which does not show up well on the photograph. The same weak
reaction was obtained in two separate experiments.
samples with recombinant protein G both ablated reactivity to
some proteins and enhanced reactivity to others. Infant sample
103 lost reactivity to the 47-kDa band after absorption (Fig. 2,
lane 19), while infant sample 50 lost reactivity to the 45-kDa
antigen but had increased reactivity to lower-molecular-mass
antigens after absorption (Fig. 2, lane 9). The intensity of the
47-kDa band increased after absorption of sera 66 and 68 (Fig.
2, lanes 13 and 15), as did the intensity of the 15-kDa band with
serum 21 (Fig. 2, lane 5).
IgA WBs. Since IgA antibodies are also markers of congen-
ital infection, we analyzed infant sera by WB with an IgA-
specific secondary antibody. Samples from the 10 infants listed
in Table 1 were also analyzed after absorption with protein G.
Six of 101 infant serum samples demonstrated reactivity in the
IgA WB (Table 1, Fig. 3). Four of the six were from symptom-
atic infants, and two were from asymptomatic infants. All six
sera reacted to the 47-kDa antigen, with variable reactivity to
higher- and lower-molecular-mass antigens. Absorption of sera
with recombinant protein G did not abolish reactivity to any
proteins but did increase the intensity of bands for several sera
(Fig. 3, lanes 7, 9, and 19).
Confirmation of IgM WB reactivity by IgM capture ELISA.
Eight of the 10 cord blood and serum samples from infants
with clinical and/or serologic evidence of congenital syphilis
were tested by IgM capture ELISA to corroborate the IgM WB
findings (Table 1). Five of five sera (100%) tested from the
symptomatic infants gave positive IgM capture ELISA results,
corroborating four of our IgM blot findings. Infant sample 56,
which was negative by IgM WB, was positive by ELISA. There
was not enough of the sixth serum for ELISA testing. Two of
three samples from the asymptomatic group were positive by
the IgM capture ELISA. Sample 103, which was negative by
WB after absorption with protein G, was reactive in the
ELISA.
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Correlation of clinical findings with IgM and IgA WB
results. Of the six symptomatic infants identified in our study,
five had reactive IgM blots (Table 1) and four had reactive IgA
blots, yielding a sensitivity of 83 and 67%, respectively. Four
asymptomatic infants had serologic evidence of infection: no.
68 and 76 had positive IgM WBs, and no. 96 and 103 had
positive IgA WBs (Table 1). One of the asymptomatic infants
(infant 76) had a reactive cerebrospinal fluid VDRL test
(Table 1). Combined use of IgM and IgA WBs yielded
serologic evidence of infection for all four of these infants,
whereas the use of either alone detected only two of the four
infants. The IgM capture ELISA was positive for two of the
three samples tested (Table 1).
As stated above, four mothers had false-positive screening
tests (i.e., negative FTA-ABS results). These sera and their
respective infant cord blood and serum samples were also
tested by WB. Two of the maternal sera gave bands on the IgG
WB, but none of the infant sera had any reactivity in an IgG,
IgM, or IgA WB.
DISCUSSION
The diagnosis of congenital syphilis is often made clinically
because standard serologic tests for syphilis, although useful in
documenting maternal infection, do not distinguish maternal
from infant antibody. In addition, many congenitally infected
infants are asymptomatic at birth, and several months may pass
before an increasing VDRL titer or persistent FTA-ABS
reactivity can be documented to confirm congenital infection.
Therefore, a reliable test to document congenital infection
soon after birth would be very helpful in the management of
infants at risk for congenital syphilis.
Serologic tests detecting IgM antibodies to infectious agents
are useful in diagnosing congenital infections (1). Of the
various techniques available to detect T. pallidum-specific IgM
antibodies, such as 19S IgM FTA-ABS, IgM ELISA, and IgM
WB, we chose the latter two to screen cord blood or serum
from 101 infants born to mothers with positive screening tests
for syphilis. WB has been shown to be a sensitive assay for the
detection of antibodies to other infectious agents (10, 27). In
addition, the documentation of reactivity to various proteins of
the infectious agent provides a high degree of specificity. These
attributes made WB an attractive choice for a serologic test for
diagnosis of congenital syphilis.
Consistent with previous reports (7, 17, 23, 24, 26, 32), the
IgM WB was very effective in confirming congenital syphilis in
symptomatic infants. Overall, six infants in our study had
symptomatic congenital syphilis. Five of these infants had
IgM-reactive blots. The IgM WB-negative, symptomatic infant
(no. 56) was born to a mother with evidence of a primary
lesion, and therefore, low levels of IgM were probably present
in this sample. Further optimization of the WB protocol may
help to increase its sensitivity. The use of a tertiary antibody
probe or an alkaline phosphatase-labeled secondary antibody
might also increase the sensitivity of our WB system. In
addition to symptomatic infants, IgM antibodies to T pallidum
were also present in two asymptomatic infants (no. 68 and 76).
The mother of infant 68 was treated 2 months before delivery,
and therefore we may have detected residual IgM antibody in
a successfully treated infant. Infant 76's mother was previously
treated but had a VDRL titer of 1:256 at delivery and 1:512 4
days before delivery, suggesting inadequate treatment or rein-
fection. Because of this high-titer maternal VDRL test and the
infant's reactive cerebrospinal fluid VDRL test, we believe that
the infant was asymptomatically infected.
Analysis of the sera from symptomatic infants by IgM
capture ELISA corroborated our IgM blot findings. Five of six
sera were positive by this method. Too little of the sixth serum
was available for ELISA testing. The IgM WB-negative serum
from infant 56 was positive by IgM capture ELISA. These
results suggest that the IgM capture ELISA may be slightly
more sensitive than the WB. In fact, the IgM capture ELISA
has been shown by others to have better sensitivity than
another assay, the 19S IgM FTA-ABS test (29). While the
ELISA may have some practical advantages in terms of assay
performance and objectivity, additional comparative studies
are needed to determine whether it performs better than WB.
We cannot comment on the specificity of the IgM capture
ELISA because not all sera were analyzed by this method.
Since IgA antibodies, like IgM, do not cross the placenta,
they are also potential markers of congenital infection. Re-
cently, the use of IgA WB for the diagnosis of congenital
human immunodeficiency virus infection yielded results supe-
rior to those obtained by IgM blotting (14, 21, 31). The use of
IgA antibodies for detecting infants at risk for congenital
syphilis was less promising than the use of IgM antibodies,
however. We detected IgA antibodies in four of six (67%)
infants with symptomatic congenital syphilis. This finding is
similar to that of Pedersen et al. (20), who demonstrated 70%
sensitivity for an IgA ELISA among a group of 10 infants born
to mothers with untreated syphilis. Two asymptomatic infants
(no. 96 and 103) were also found to have positive IgA blots.
Their mothers reported treatment for syphilis 5 months and 2
years before delivery, respectively. Thus, the significance of the
reactive IgA blots is not clear, although reinfection or treat-
ment failure cannot be ruled out. Further follow-up of these
infants would be desirable but is not possible for our study.
Like the IgM blots, all the IgA-positive blots reacted to the
47-kDa antigen. In addition, both higher- and lower-molecu-
lar-mass proteins were recognized by some of the samples. In
general, however, the intensity of the bands was less than in
IgM blots.
Comparative mother-infant IgG WBs were also performed
for the symptomatic infants in this study. Our present finding
that the reactivity of maternal and infant sera is very similar is
not surprising. One would expect the presence of maternally
acquired IgG in the infant's serum to result in similar WB
patterns. We, however, found two sera from congenitally
infected, symptomatic infants that contained antibodies to a
spirochetal protein not recognized, or only weakly recognized,
by their respective maternal sera. This protein may correspond
to the 83-kDa protein described by Dobson et al. (7). However,
our findings suggest that the usefulness of the reaction is
limited because of its infrequent occurrence. We did not notice
differences in IgG WB results for asymptomatic infant-mother
pairs.
A much more consistent finding was IgM and IgA reactivity
to the 47-kDa antigen by sera from infants at risk for congen-
ital syphilis. As in other studies (7, 17, 23-25), the majority of
our IgM-reactive sera (seven of eight) demonstrated this
reactivity. We found much less reactivity to other proteins,
such as those of 45, 17, and 15 kDa. We may be able to improve
the reactivity to other proteins, however, by using Triton X-114
phase partitioning to enrich for lipoproteins, as described by
Sanchez et al. (24). The infant sample (no. 76) with IgM
reactivity to a protein of approximately 93 kDa (and not to the
47-kDa protein) was an unexpected finding. While the mater-
nal serum reacted to this protein, it also recognized 47- and
45-kDa proteins with similar intensity. The 47- and 45-kDa
bands, however, were not seen with the infant's sample. Thus,
we do not believe that the reactivity of the infant's sample was
due to contamination by maternal blood.
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Potential drawbacks to IgM WB include interference from
RF and high concentrations of T. pallidum-specific IgG anti-
bodies, which may compete with IgM and IgA antibodies.
These factors can result in false-positive and false-negative
IgM serological tests, respectively. It is important to study the
effect of these potential interferences in IgM WB for congen-
ital syphilis because many infected infants have RF (18, 22).
We detected RF in four of eight infant sera tested. In one case
(infant 103), removal of IgG by protein G absorption changed
the blot result to negative (reactivity to the 47-kDa antigen was
abolished). We do not believe that this represents aberrant
removal of T. pallidum-specific IgM from the sample because
decreased IgM reactivity was not noted to occur in other
samples after absorption (even in RF-negative samples). In
addition, several sera demonstrated increased IgM and IgA
band intensities after absorption of IgG, suggesting competi-
tion between the two isotypes of antibody and not removal of
IgM or IgA antibodies. Since these interfering substances can
cause problems in syphilis IgM blotting assays, we believe that
it is prudent to absorb IgG from the patient's serum sample
before testing. Others have noted alterations in WB profiles
after absorption of IgG from sera (17).
Our findings confirm those of previous studies demonstrat-
ing the utility of IgM WB in the diagnosis of congenital syphilis
(7, 17, 23, 24-26, 32). In addition, our data suggest that IgA
antibodies detectable by WB can be used as additional markers
of congenital syphilis. Further development of IgM and IgA
serologic tests and DNA amplification techniques should
greatly facilitate the diagnosis of congenital syphilis.
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